Shared insight on the evolving state of renal cell carcinoma management and hope for future growth in the treatment landscape.
Brian I. Rini, MD, Cleveland Clinic
Advertisement
Articles by Brian I. Rini, MD, Cleveland Clinic
Expert perspectives on the adverse event profiles of first-line combination therapies in the advanced clear cell renal cell carcinoma space.
Advertisement
Latest Updated Articles
Renal Cell Carcinoma: Future Evolutions in CarePublished: July 24th 2023 | Updated:
Advanced Clear Cell RCC: AE Profile of First-Line Combination TherapiesPublished: July 3rd 2023 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
Oncology Fellows Highlights 2025 ESMO Fellowship Winners
5